These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology. Kovarnik T; Chen Z; Mintz GS; Wahle A; Bayerova K; Kral A; Chval M; Kopriva K; Lopez J; Sonka M; Linhart A Cardiovasc Diabetol; 2017 Dec; 16(1):156. PubMed ID: 29212544 [TBL] [Abstract][Full Text] [Related]
9. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events. Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546 [TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis. Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC Circ J; 2011; 75(2):398-406. PubMed ID: 21157106 [TBL] [Abstract][Full Text] [Related]
16. Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study. Nicholls SJ; Tuzcu EM; Wolski K; Bayturan O; Lavoie A; Uno K; Kupfer S; Perez A; Nesto R; Nissen SE J Am Coll Cardiol; 2011 Jan; 57(2):153-9. PubMed ID: 21211686 [TBL] [Abstract][Full Text] [Related]
17. Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease. Elshazly MB; Mani P; Nissen S; Brennan DM; Clark D; Martin S; Jones SR; Quispe R; Donnellan E; Nicholls SJ; Puri R Eur J Prev Cardiol; 2020 Jul; 27(10):1091-1100. PubMed ID: 31744333 [TBL] [Abstract][Full Text] [Related]
18. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy. Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743 [TBL] [Abstract][Full Text] [Related]